| To: deeno who wrote (760) | 8/9/2013 5:18:03 PM | | From: Sr K | | | | Carl Icahn 8-K filed today shows he sold another 33,870 calls and paired puts (representing 3.387 million shares) on 8/7, 8/8, and 8/9, as shown in this footnote:
8. The Call Options reference an aggregate of 19,480,102 Shares, have an exercise price of $12.30, expire on February 20, 2015, and provide for physical settlement. The Put Options reference an aggregate of 19,480,102 Shares, have an exercise price of $12.30, expire on February 20, 2015, and provide that they settle in cash. |
| | Nuance Communications, Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Sr K | 9/5/2013 10:18:39 AM | | | | | | Nuance Brings Intelligent Voice Experience to S-Voice on New Samsung GALAXY Gear and Samsung GALAXY Note 3
Nuance’s Voice and Language Technologies Debut on Samsung’s New Smart Watch, Featured as Part of New Cross-Device Mobile Assistant Experience
 Press Release: Nuance Communications Inc. – 2 hours 17 minutes ago
finance.yahoo.com |
| | Nuance Communications, Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Sr K | 9/10/2013 4:40:25 PM | | | | | | Revealed in Form 4 for 9/6/2013, Paul Ricci is a limited partner of Warburg Pincus Private Equity X, L.P.
1. Pro rata distribution from Warburg Pincus Private Equity X, L.P. of which reporting person is a limited partner.
He got (only) 555 shares. |
| | Nuance Communications, Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Savant | 11/25/2013 10:20:51 AM | | | | | | | Nuance Announces Next-Generation Dragon Medical, Setting New Benchmarks for Accuracy, Speed and Ease of Use | Helping Physicians Become More Efficient and Remain Focused on Patient Care
BURLINGTON, Mass.--(BUSINESS WIRE)--November 25, 2013--
Nuance Communications, Inc. (NASDAQ: NUAN) announced today the general availability of Dragon Medical 360 Network Edition 2.0, which delivers unparalleled accuracy and performance using the newest version of Nuance's superior speech engine. This flexible platform is designed for clinicians documenting clinical care using multiple devices and electronic health records (EHRs) across a hospital or health system. The new release supports enhanced real-time dictation on any desktop/PC, laptop or mobile device, as well as within virtualized, browser-based and client-server EHR environments.
Even Better Speech Performance
Using Nuance's latest advancements in voice and natural language understanding technologies, Dragon Medical 360 | Network Edition 2.0 offers up to 98 percent or higher accuracy out of the box, with no voice training needed. Clinicians using version 2.0 experience 20 percent fewer errors than the prior version of Network Edition, producing an even more positive and consistent experience and rapid adoption of the technology. Clinicians already using these solutions in their everyday routines can now more easily document patient care from any device using Dragon Medical directly in both desktop and mobile EHRs, including Cerner's PowerChart Touch(TM) and Epic's Haiku and Canto.
"For physicians, it's all about maximizing time and getting through their busy day without having to leave the office with homework. No one wants to spend two to three hours at the end of a shift documenting patient care. Even our most skeptical physicians, including those who speak rapidly or have strong accents, are seeing the benefits of dictating with Dragon Medical Network Edition 2.0," explains Peter Malloy, CIO, Cheshire Medical Center/Dartmouth-Hitchcock Keene. "Basically, doctors are able to improve their efficiency. The benefit for physicians and medical recordkeeping is faster, end-to-end completion of the note."
Optimized for Any Environment
Dragon Medical 360 | Network Edition 2.0 is part of Nuance's Dragon Medical 360 platform, which enables clinicians to easily access Nuance's reliable speech recognition technology anywhere, on any device at any time to fit their preferred workflow. As hospitals merge and health systems deploy EHR physician documentation software across multiple IT environments, clinicians need to maintain focus on delivering patient care instead of documenting that care.
Designed to meet the shifting needs of providers, the new platform supports all types of virtualized network environments, allowing organizations to seamlessly integrate with EHRs to drive easy adoption, improve usability, and maximize performance. Dragon Medical accelerates clinical documentation in Allscripts, Cerner, eClinicalWorks, Epic, Meditech, NextGen and other leading EHRs, enabling physicians to capture their patients' stories at the hospital, in the office, or on-the-go. Nearly 300,000 physicians already rely on Dragon Medical 360, Nuance's industry-leading speech-recognition technology, to simplify and speed clinical documentation so they can focus more time on patient care.
"With increasing patient volumes, we need to maximize our time, so mobility and usability are king. We want to spend our time treating our patients, not entering information about them -- that is something we can do on the go. Dragon Medical fits into our workflow, it doesn't determine it," says Cindy Peterson, vice president and CIO, Henry Mayo Newhall Memorial Hospital, which has deployed Dragon Medical 360 | Network Edition with its Meditech EHR.
For more information on how Dragon Medical 360 Network Edition 2.0 helps healthcare providers fully optimize their EHR system, register for our upcoming webinar, Best Practices for EHR Adoption Success, Thursday, December 5 at 12:00 p.m. ET. This webinar will feature advice and strategic insights from experts at The Cleveland Clinic and The Henry Mayo Newhall Memorial Hospital.
Connect with Nuance on social media through the healthcare blog, What's next, as well as Twitter and Facebook.
About Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance's proven applications. For more information, please visit: nuance.com.
Nuance and the Nuance logo are trademarks or registered trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other company names or product names may be the trademarks of their respective owners.
|
| | Nuance Communications, Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Savant | 11/25/2013 7:36:24 PM | | | | | | | Nuance Announces Fiscal 2013 and Fourth Quarter Results & CC | Nuance Delivers 12.6% FY 13 Revenue Growth; Key Customer Wins Demonstrate Progress in Attractive New Markets with Recurring Revenue Models
BURLINGTON, Mass.--(BUSINESS WIRE)--November 25, 2013--
Nuance Communications, Inc. (NASDAQ: NUAN) today announced financial results for its fiscal 2013 and fourth quarter, ended September 30, 2013.
In fiscal 2013, Nuance reported GAAP revenue of $1,855.3 million, a 12.3% increase over GAAP revenue of $1,651.5 million in fiscal 2012. In fiscal 2013, Nuance reported non-GAAP revenue of $1,957.7 million, which includes $102.4 million in revenue lost to accounting treatment in conjunction with acquisitions. Fiscal 2013 non-GAAP revenue grew 12.6% over non-GAAP revenue of $1,738.1 million in fiscal 2012.
In fiscal 2013, Nuance recognized GAAP net loss of ($115.2) million, or ($0.37) per share, compared with GAAP net income of $207.1 million, or $0.65 per diluted share, in fiscal 2012. In fiscal 2013, Nuance reported non-GAAP net income of $428.0 million, or $1.33 per diluted share, compared to $555.9 million, or $1.73 per diluted share, in fiscal 2012. Nuance's fiscal 2013 non-GAAP operating margin was 27.9%, compared to 35.8% in fiscal 2012. Nuance reported cash flow from operations of $395.0 million in fiscal 2013, compared to $473.0 million in fiscal 2012. Nuance ended fiscal 2013 with a balance of cash, cash equivalents and marketable securities of $846.8 million. As of September, Nuance had repurchased 9.805 million shares of common stock, for a total amount of $184.4 million at an average price per share of $18.81.
In the fourth quarter of fiscal 2013, Nuance reported GAAP revenue of $472.2 million, compared to $468.8 million in the fourth quarter of fiscal 2012. Nuance reported non-GAAP revenue of $490.4 million, which includes $18.2 million in revenue lost to accounting treatment in conjunction with acquisitions, compared to $490.1 million in the fourth quarter of fiscal 2012.
In the fourth quarter of fiscal 2013, Nuance recognized GAAP net loss of ($32.3) million, or ($0.10) per share, compared with GAAP net income of $117.6 million, or $0.36 per diluted share, in the fourth quarter of fiscal 2012. In the fourth quarter of fiscal 2013, Nuance reported non-GAAP net income of $95.2 million, or $0.30 per diluted share, compared to non-GAAP net income of $164.9 million, or $0.51 per diluted share, in the fourth quarter of fiscal 2012. Nuance's fourth quarter fiscal 2013 non-GAAP operating margin was 25.3%, down from 37.2% in the fourth quarter of fiscal 2012. Nuance reported cash flow from operations of $93.5 million in the fourth quarter of fiscal 2013, down from $141.5 million in the fourth quarter of fiscal 2012.
Please refer to the "Discussion of Non-GAAP Financial Measures" and to the "GAAP to Non-GAAP Reconciliations," included elsewhere in this release, for more information regarding the company's use of non-GAAP measures.
"We are pleased that we achieved fourth quarter results consistent with our guidance, and executed on our strategy to enter new growth markets, deliver a new generation of solutions and enable attractive, recurring revenue streams," said Paul Ricci, Nuance Chairman and CEO.
Highlights from the quarter include:
-- Healthcare -- For Nuance's healthcare solutions, fourth quarter fiscal 2013 non-GAAP revenue was $226.7 million and fiscal 2013 non-GAAP revenue was $911.6 million. We secured new business with key healthcare customers including Adventist, Brigham and Women's Hospital, Brooklyn Hospital, Hackensack University, Steward, SW General, Tenet, UAB, UMH, Union, Unity, US Veterans Administration and Wilson. -- Mobile & Consumer -- For Nuance's mobile and consumer solutions, fourth quarter fiscal 2013 non-GAAP revenue was $120.3 million and fiscal 2013 non-GAAP revenue was $479.2 million. We secured new business or design wins with key mobile customers including Charter Communications, Cisco, Daimler, DoCoMo, GM, Huawei, Hyundai, iMobile, Kyocera, Mahindra, Motospeak, Nissan, Nokia, Panasonic, Roadtrack, Samsung, TCL CarTel, Telstra, TIM Brazil, Toyota, Verizon, Vodafone Spain, Vonage and VW. -- Enterprise -- For Nuance's enterprise solutions, fourth quarter fiscal 2013 non-GAAP revenue was $86.4 million and fiscal 2013 non-GAAP revenue was $323.5 million. We secured new business with key enterprise customers including Allstate, Australia Department of Health Services, Barclays, Cathay Pacific, Charles Schwab, CIBC, DBS Bank, FIS, Garanti Bank, ING, Kaiser, Korea Telecomm, Nice, Optus, PG&E, Prime Therapeutics, PSE&G, Singtel, State of Illinois, TalkTalk, U.K. HM Revenue & Customs, Verint, Vodafone, VSP, WellPoint, Wells Fargo and Windstream. -- Imaging -- For Nuance's document imaging solutions, fourth quarter fiscal 2013 non-GAAP revenue was $57.0 million and fiscal 2013 non-GAAP revenue was $243.4 million. We secured new business with key imaging customers including Adidas, Bank Danamon, Bart's, Canon, City of Edmonton, Datev, HP, Ikea, Kodak, Nationwide, Ricoh, Steptoe & Johnson and Xerox.
Conference Call and Prepared Remarks
Nuance is providing a copy of prepared remarks in combination with its press release. These remarks are offered to provide shareholders and analysts with additional time and detail for analyzing results in advance of the company's quarterly conference call. The remarks will be available at nuance.com in conjunction with the press release.
As previously scheduled, the conference call will begin today, November 25, 2013 at 5:00 pm EST and will include only brief comments followed by questions and answers. The prepared remarks will not be read on the call. To access the live broadcast, please visit the Investor Relations section of Nuance's Website at www.nuance.com. The call can also be heard by dialing (800) 230-1074 or (612) 288-0329 at least five minutes prior to the call and referencing code 304712. A replay will be available within 24 hours of the announcement by dialing (800) 475-6701 or (320) 365-3844 and using the access code 304712.
About Nuance Communications, Inc
Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance's proven applications. For more information, please visit www.nuance.com.
Trademark reference: Nuance, the Nuance logo, Dragon Medical and eScription are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.
Safe Harbor and Forward-Looking Statements |
| | Nuance Communications, Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Jorgen Jensen | 11/30/2013 5:55:30 PM | | | | | | Here are some of the analyst ratings changes after the disappointing earnings report:
Piper Jaffray $19 to $14
Wedbush Sell $22 to $15
Oppenheimer Sell
Deutsche Bank Buy
Zacks Neutral $16
Craig Hallum $20- to $12
UBS Neutral
Canaccord Buy
Standpoint Buy $18- |
| | Nuance Communications, Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |
